尋找研究成果

文章

APEG-1, a novel gene preferentially expressed in aortic smooth muscle cells, is down-regulated by vascular injury

Hsieh, C. M., Yoshizumi, M., Endege, W. O., Kho, C. J., Jain, M. K., Kashiki, S., De los Santos, R., Leet, W. S., Perrella, M. A. & Lee, M. E., 1996, 於: Journal of Biological Chemistry. 271, 29, p. 17354-17359 6 p.

研究成果: 雜誌貢獻 › 文章 › 同行評審

38 引文斯高帕斯（Scopus）

Apelin regulates the electrophysiological characteristics of atrial myocytes

Cheng, C. C., Weerateerangkul, P., Lu, Y. Y., Chen, Y. C., Lin, Y. K., Chen, S. A. & Chen, Y. J., 一月 2013, 於: European Journal of Clinical Investigation. 43, 1, p. 34-40 7 p.

研究成果: 雜誌貢獻 › 文章 › 同行評審

13 引文斯高帕斯（Scopus）

A Penetrating Tracheal Injury Caused by a Needlefish

Yang, C-C., Huang, C-M., Lu, L-H., Choi, W. M., Tsai, S-H., Chiu, W-T. & Liu, H-C., 2004, 於: 中華民國急救加護醫學會雜誌. 15, 2, p. 70-74 5 p.

研究成果: 雜誌貢獻 › 文章 › 同行評審

A persistent level of CISD2 extends healthy lifespan and delays aging in mice

Wu, C. Y., Chen, Y. F., Wang, C. H., Kao, C. H., Zhuang, H. W., Chen, C. C., Chen, L. K., Kirby, R., Wei, Y. H., Tsai, S. F. & Tsai, T. F., 九月 2012, 於: Human Molecular Genetics. 21, 18, p. 3956-3968 13 p., dds210.

研究成果: 雜誌貢獻 › 文章 › 同行評審

64 引文斯高帕斯（Scopus）

A personalized medication management platform (PMMP) to improve medication adherence: A randomized control trial

Huang, C. Y., Nguyen, P. A. A., Clinciu, D. L., Hsu, C. K., Lu, J. C. R., Yang, H. C., Wu, C. C., Tsai, W. C., Chou, Y. C., Kuo, T. B. J., Chang, P. L., Jian, W. S. & Li, Y. C. J., 三月 1 2017, 於: Computer Methods and Programs in Biomedicine. 140, p. 275-281 7 p.

研究成果: 雜誌貢獻 › 文章 › 同行評審

11 引文斯高帕斯（Scopus）

A Phantom Study of the Spatial Precision and Accuracy of Stereotactic Localization Using Computed Tomography Imaging with the Leksell Stereotactic System

Tafreshi, A. R., Peng, T., Yu, C., Kramer, D. R., Gogia, A. S., Lee, M. B., Barbaro, M. F., Sebastian, R., Del Campo-Vera, R. M., Chen, K. H., Kellis, S. S. & Lee, B., 七月 2020, 於: World Neurosurgery. 139, p. e297-e307

研究成果: 雜誌貢獻 › 文章 › 同行評審

A Pharmacist-initiated Project to Reduce Meperidine Use in Surgical Patients

Wu, M. T., Wu, T. Y., Tai, Y-T., Chen, H. Y. & Kuo, L. N., 八月 2012, 於: Journal of Experimental and Clinical Medicine(Taiwan). 4, 4, p. 245-248 4 p.

研究成果: 雜誌貢獻 › 文章 › 同行評審

5 引文斯高帕斯（Scopus）

A pharmacokinetic and pharmacodynamic study of intravenous levosimendan in healthy Chinese volunteers and ethnic comparisons

Chu, K. M., Hu, O. Y. P. & Liou, J. T., 一月 1 2014, 於: Acta Cardiologica Sinica. 30, 4, p. 298-307 10 p.

研究成果: 雜誌貢獻 › 文章 › 同行評審

5 引文斯高帕斯（Scopus）

A pharmacokinetic study with the high-dose anticancer agent menadione in rabbits

Hu, O. Y. P., Wu, C. Y., Chan, W. K., Wu, F. Y. H. & Whang-Peng, J., 八月 1 1996, 於: Biopharmaceutics and Drug Disposition. 17, 6, p. 493-499 7 p.

研究成果: 雜誌貢獻 › 文章 › 同行評審

9 引文斯高帕斯（Scopus）

A phase I/II study of GTI-2040 plus docetaxel as second-line treatment in advanced non-small cell lung cancer: A study of the PMH phase II consortium

Leighl, N. B., Laurie, S. A., Chen, X. E., Ellis, P., Shepherd, F. A., Knox, J. J., Goss, G., Burkes, R. L., Pond, G. R., Dick, C., Yen, Y., Zwiebel, J. A. & Moore, M. J., 一月 1 2009, 於: Journal of Thoracic Oncology. 4, 9, p. 1163-1169 7 p.

研究成果: 雜誌貢獻 › 文章 › 同行評審

15 引文斯高帕斯（Scopus）

A Phase I/II study of the combination of lapatinib and oral vinorelbine in HER2-positive metastatic breast cancer

Chen, T. W-W., Yeh, D-C., Chao, T-Y., Lin, C-H., Chow, L. W-C., Chang, D-Y., Hsieh, Y-Y., Huang, S-M., Cheng, A-L. & Lu, Y-S., 三月 1 2018, 於: Japanese Journal of Clinical Oncology. 48, 3, p. 242-247 6 p.

研究成果: 雜誌貢獻 › 文章 › 同行評審

3 引文斯高帕斯（Scopus）

A phase I and pharmacokinetic study of oral 3-aminopyridine-2- carboxaldehyde thiosemicarbazone (3-AP, NSC #663249) in the treatment of advanced-stage solid cancers: A California Cancer Consortium Study

Chao, J., Synold, T. W., Morgan, R. J., Kunos, C., Longmate, J., Lenz, H. J., Lim, D., Shibata, S., Chung, V., Stoller, R. G., Belani, C. P., Gandara, D. R., McNamara, M., Gitlitz, B. J., Lau, D. H., Ramalingam, S. S., Davies, A., Espinoza-Delgado, I., Newman, E. M. & Yen, Y., 三月 2012, 於: Cancer Chemotherapy and Pharmacology. 69, 3, p. 835-843 9 p.

研究成果: 雜誌貢獻 › 文章 › 同行評審

33 引文斯高帕斯（Scopus）

A phase i clinical study of immunotherapy for advanced colorectal cancers using carcinoembryonic antigen-pulsed dendritic cells mixed with tetanus toxoid and subsequent IL-2 treatment John T Kung

Liu, K. J., Chao, T. Y., Chang, J. Y., Cheng, A. L., Ch'Ang, H. J., Kao, W. Y., Wu, Y. C., Yu, W. L., Chung, T. R. & Whang-Peng, J., 八月 24 2016, 於: Journal of Biomedical Science. 23, 1, 64.

研究成果: 雜誌貢獻 › 文章 › 同行評審

12 引文斯高帕斯（Scopus）

A phase I dose-escalation study of PEP02 (irinotecan liposome injection) in combination with 5-fluorouracil and leucovorin in advanced solid tumors

Chiang, N. J., Chao, T. Y., Hsieh, R. K., Wang, C. H., Wang, Y. W., Yeh, C. G. & Chen, L. T., 十一月 21 2016, 於: BMC Cancer. 16, 1, 907.

研究成果: 雜誌貢獻 › 文章 › 同行評審

21 引文斯高帕斯（Scopus）

A phase I feasibility and pharmacokinetic study of intrapleural paclitaxel in patients with malignant pleural effusions

Perng, R. P., Wu, M. F., Lin, S. Y., Chen, Y. M., Lin, J. Y. & Whang-Peng, J., 九月 16 1997, 於: Anti-Cancer Drugs. 8, 6, p. 565-573 9 p.

研究成果: 雜誌貢獻 › 文章 › 同行評審

21 引文斯高帕斯（Scopus）

A phase II and pharmacokinetic study of first line S-1 for advanced gastric cancer in Taiwan

Chen, J. S., Chao, Y., Hsieh, R. K., Cheng, A. L., Chen, P. M., Chiou, T. J., Chao, T. Y., Yeh, K. H., Chen, L. T. & Whang-Peng, J., 六月 2011, 於: Cancer Chemotherapy and Pharmacology. 67, 6, p. 1281-1289 9 p.

研究成果: 雜誌貢獻 › 文章 › 同行評審

6 引文斯高帕斯（Scopus）

A Phase II Clinical Trial on the Combination Therapy of PHY906 Plus Capecitabine in Hepatocellular Carcinoma

Changou, C. A., Shiah, H. S., Chen, L. T., Liu, S., Luh, F., Liu, S. H., Cheng, Y. C. & Yen, Y., 2020, (接受/付印) 於: Oncologist. 26, 3, p. e367-e373

研究成果: 雜誌貢獻 › 文章 › 同行評審

開啟存取

3 引文斯高帕斯（Scopus）

A phase II double-blinded study to evaluate the efficacy of EW02 in reducing chemotherapy-induced neutropenia in breast cancer

Wu, Y. Y., Liu, H. Y., Huang, T. C., Chen, J. H., Chang, P. Y., Ho, C. L. & Chao, T. Y., 九月 1 2015, 於: Oncology Letters. 10, 3, p. 1793-1798 6 p.

研究成果: 雜誌貢獻 › 文章 › 同行評審

1 引文斯高帕斯（Scopus）

A phase II randomized study of paclitaxel plus carboplatin or cisplatin against chemo-naive inoperable non-small cell lung cancer in the elderly

Chen, Y. M., Perng, R. P., Tsai, C. M. & Whang-Peng, J., 二月 1 2006, 於: Journal of Thoracic Oncology. 1, 2, p. 141-145 5 p.

研究成果: 雜誌貢獻 › 文章 › 同行評審

24 引文斯高帕斯（Scopus）

A phase II randomized study of vinorelbine alone or with cisplatin against chemo-naïve inoperable non-small cell lung cancer in the elderly

Chen, Y. M., Perng, R. P., Shih, J. F. & Whang-Peng, J., 八月 2008, 於: Lung Cancer. 61, 2, p. 214-219 6 p.

研究成果: 雜誌貢獻 › 文章 › 同行評審

19 引文斯高帕斯（Scopus）

A phase II randomized trial of gefitinib alone or with Tegafur/uracil treatment in patients with pulmonary adenocarcinoma who had failed previous chemotherapy

Chen, Y. M., Fan, W. C., Tsai, C. M., Liu, S. H., Shih, J. F., Chou, T. Y., Wu, C. H., Chou, K. T., Lee, Y. C., Perng, R. P. & Whang-Peng, J., 六月 2011, 於: Journal of Thoracic Oncology. 6, 6, p. 1110-1116 7 p.

研究成果: 雜誌貢獻 › 文章 › 同行評審

24 引文斯高帕斯（Scopus）

A phase ii study of carboplatin in nasopharyngeal carcinoma

Chi, K. H., Chang, Y. C., Chan, W. K., Liu, J. M., Law, C. K., Lo, S. S., Shu, C. H., Yen, S. H., Whang-Peng, J. & Chen, K. Y., 一月 1 1997, 於: Oncology (Switzerland). 54, 3, p. 203-207 5 p.

研究成果: 雜誌貢獻 › 文章 › 同行評審

11 引文斯高帕斯（Scopus）

A phase II study of erlotinib in combination with bevacizumab versus chemotherapy plus bevacizumab in the first-line treatment of advanced non-squamous non-small cell lung cancer

Ciuleanu, T., Tsai, C. M., Tsao, C. J., Milanowski, J., Amoroso, D., Heo, D. S., Groen, H. J. M., Szczesna, A., Chung, C. Y., Chao, T. Y., Middleton, G., Zeaiter, A., Klingelschmitt, G., Klughammer, B. & Thatcher, N., 十一月 2013, 於: Lung Cancer. 82, 2, p. 276-281 6 p.

研究成果: 雜誌貢獻 › 文章 › 同行評審

31 引文斯高帕斯（Scopus）

A phase II study of hydroxyurea combined with gemcitabine in patients with head and neck squamous carcinoma and gene expression profiles correlated to poor response

Zhang, K., Kim, C., Wu, X., Loera, S., Wang, Y., Chu, P., Lim, D., Shibata, S. & Yen, Y., 二月 27 2013, 於: Head and Neck Oncology. 5, 3, 3.

研究成果: 雜誌貢獻 › 文章 › 同行評審

A phase II study of lapatinib in patients with advanced biliary tree and hepatocellular cancer

Ramanathan, R. K., Belani, C. P., Singh, D. A., Tanaka, M., Lenz, H. J., Yen, Y., Kindler, H. L., Iqbal, S., Longmate, J., MacK, P. C., Lurje, G., Gandour-Edwards, R., Dancey, J. & Gandara, D. R., 九月 1 2009, 於: Cancer Chemotherapy and Pharmacology. 64, 4, p. 777-783 7 p.

研究成果: 雜誌貢獻 › 文章 › 同行評審

220 引文斯高帕斯（Scopus）

A phase II study of S-1 plus oral leucovorin in heavily treated metastatic colorectal cancer patients

Hsu, H. C., Chou, W. C., Kuan, F. C., Lee, K. D., Rau, K. M., Huang, J. S. & Yang, T. S., 一月 1 2018, 於: Cancer Management and Research. 10, p. 6061-6070 10 p.

研究成果: 雜誌貢獻 › 文章 › 同行評審

3 引文斯高帕斯（Scopus）

A phase II study of the antisense oligonucleotide GTI-2040 plus docetaxel and prednisone as first-line treatment in castration-resistant prostate cancer

Sridhar, S. S., Canil, C. M., Chi, K. N., Hotte, S. J., Ernst, S., Wang, L., Chen, E. X., Juhasz, A., Yen, Y., Murray, P., Zwiebel, J. A. & Moore, M. J., 四月 1 2011, 於: Cancer Chemotherapy and Pharmacology. 67, 4, p. 927-933 7 p.

研究成果: 雜誌貢獻 › 文章 › 同行評審

21 引文斯高帕斯（Scopus）

A phase II study of weekly docetaxel and cisplatin plus oral tegafur/uracil and leucovorin as first-line chemotherapy in patients with locally advanced or metastatic gastric cancer

Li, C. P., Chen, J. S., Chen, L. T., Yen, C. J., Lee, K. D., Su, W. P., Lin, P. C., Lu, C. H., Tsai, H. J. & Chao, Y., 十月 26 2010, 於: British Journal of Cancer. 103, 9, p. 1343-1348 6 p.

研究成果: 雜誌貢獻 › 文章 › 同行評審

14 引文斯高帕斯（Scopus）

A phase II study of weekly paclitaxel and epirubicin in recurrent or refractory squamous cell carcinoma of the head and neck

Wang, T. F., Chu, S. C., Kao, R. H., Yao, C. Y. & Li, C. C., 八月 12 2008, 於: Japanese Journal of Clinical Oncology. 38, 7, p. 459-463 5 p.

研究成果: 雜誌貢獻 › 文章 › 同行評審

3 引文斯高帕斯（Scopus）

A phase II trial of biweekly oxaliplatin with simplified schedule of 48-h infusion of high-dose 5-fluorouracil and leucorvin for advanced biliary tract carcinoma

Chen, J. S., Chao, Y., Yang, T. S., Chou, W. C., Chen, L. T., Lee, K. D. & Lin, Y. C., 2009, 於: Cancer Chemotherapy and Pharmacology. 65, 1, p. 151-157 7 p.

研究成果: 雜誌貢獻 › 文章 › 同行評審

5 引文斯高帕斯（Scopus）

A phase II trial of gemcitabine plus UFUR combination chemotherapy in non-small-cell lung cancer patients failing previous chemotherapy

Chen, Y. M., Perng, R. P., Tsai, C. M. & Whang-Peng, J., 六月 1 2006, 於: Lung Cancer. 52, 3, p. 333-338 6 p.

研究成果: 雜誌貢獻 › 文章 › 同行評審

7 引文斯高帕斯（Scopus）

A phase II trial of tamoxifen, ifosfamide, epirubicin, and cisplatin combination chemotherapy for inoperable non-small-cell lung cancer

Chen, Y. M., Perng, R. P., Yang, K. Y., Lin, W. C., Wu, H. W., Liu, J. M., Tsai, C. M. & Whang-Peng, J., 二月 1 2000, 於: American Journal of Clinical Oncology: Cancer Clinical Trials. 23, 1, p. 13-17 5 p.

研究成果: 雜誌貢獻 › 文章 › 同行評審

15 引文斯高帕斯（Scopus）

A phase II trial of vinorelbine and cisplatin in previously untreated inoperable non-small-cell lung cancer

Perng, R. P., Shih, J. F., Chen, Y. M., Delgado, F. M., Tsai, C. M., Chou, K. C., Liu, J. M., Chern, M. S. & Whang-Peng, J., 二月 1 2000, 於: American Journal of Clinical Oncology: Cancer Clinical Trials. 23, 1, p. 60-64 5 p.

研究成果: 雜誌貢獻 › 文章 › 同行評審

11 引文斯高帕斯（Scopus）

A phase II trial of vinorelbine plus gemcitabine in previously untreated inoperable (stage IIIb/IV) non-small-cell lung cancer patients aged 80 or older

Chen, Y. M., Perng, R. P., Chen, M. C., Tsai, C. M., Ming-Liu, J. & Whang-Peng, J., 五月 1 2003, 於: Lung Cancer. 40, 2, p. 221-226 6 p.

研究成果: 雜誌貢獻 › 文章 › 同行評審

23 引文斯高帕斯（Scopus）

A phase I pharmacodynamic study of GTI-2040, an antisense oligonucleotide against ribonuclotide reductase, in acute leukemias: a California Cancer Consortium study

Kirschbaum, M. H., Frankel, P., Synold, T. W., Xie, Z., Yen, Y., Popplewell, L., Chen, R., Aljitawi, O., Tuscano, J. M., Chan, K. K. & Newman, E. M., 十月 2 2016, 於: Leukemia and Lymphoma. 57, 10, p. 2307-2314 8 p.

研究成果: 雜誌貢獻 › 文章 › 同行評審

3 引文斯高帕斯（Scopus）

A phase-I study evaluating the combination of pegylated liposomal doxorubicin and paclitaxel as salvage chemotherapy in metastatic breast cancer previously treated with anthracycline

Hong, R. L., Lin, C. H., Chao, T. Y., Kao, W. Y., Wang, C. H., Hsieh, R. K. & Hwang, W. S., 四月 2008, 於: Cancer Chemotherapy and Pharmacology. 61, 5, p. 847-853 7 p.

研究成果: 雜誌貢獻 › 文章 › 同行評審

8 引文斯高帕斯（Scopus）

A phase I study of carboplatin and etoposide administered in conjunction with dipyridamole, prochlorperazine and cyclosporine A

Raschko, J. W., Synold, T. W., Chow, W., Coluzzi, P., Hamasaki, V., Leong, L. A., Margolin, K. A., Morgan, R. J., Shibata, S. I., Somlo, G., Tetef, M. L., Yen, Y., Ter Veer, A. & Doroshow, J. H., 2000, 於: Cancer Chemotherapy and Pharmacology. 46, 5, p. 403-410 8 p.

研究成果: 雜誌貢獻 › 文章 › 同行評審

7 引文斯高帕斯（Scopus）

A phase I study of oxaliplatin in combination with gemcitabine: Correlation of clinical outcome with gene expression

Shibata, S., Chow, W., Frankel, P., Juhasz, A., Leong, L., Lim, D., Margolin, K., Morgan, R., Newman, E., Somlo, G., Yen, Y., Synold, T., Gandara, D., Lenz, H. J. & Doroshow, J., 三月 1 2007, 於: Cancer Chemotherapy and Pharmacology. 59, 4, p. 549-557 9 p.

研究成果: 雜誌貢獻 › 文章 › 同行評審

4 引文斯高帕斯（Scopus）

A phase i study of prolonged infusion of triapine in combination with fixed dose rate gemcitabine in patients with advanced solid tumors

Mortazavi, A., Ling, Y., Martin, L. K., Wei, L., Phelps, M. A., Liu, Z., Harper, E. J., Ivy, S. P., Wu, X., Zhou, B. S., Liu, X., Deam, D., Monk, J. P., Hicks, W. J., Yen, Y., Otterson, G. A., Grever, M. R. & Bekaii-Saab, T., 六月 1 2013, 於: Investigational New Drugs. 31, 3, p. 685-695 11 p.

研究成果: 雜誌貢獻 › 文章 › 同行評審

21 引文斯高帕斯（Scopus）

A phase I study of weekly docetaxel, 24-hour infusion of high-dose fluorouracil/leucovorin and cisplatin in patients with advanced gastric cancer

Chen, L. T., Liu, T. W., Wu, C. W., Chung, T. R., Shiah, H. S., Jan, C. M., Ming Liu, J., Whang-Peng, J. & Chang, J. Y., 十二月 1 2002, 於: Oncology. 63, 3, p. 239-247 9 p.

研究成果: 雜誌貢獻 › 文章 › 同行評審

17 引文斯高帕斯（Scopus）

A phase I trial of 3-aminopyridine-2-carboxaldehyde thiosemicarbazone in combination with gemcitabine for patients with advanced cancer

Yen, Y., Margolin, K., Doroshow, J., Fishman, M., Johnson, B., Clairmont, C., Sullivan, D. & Sznol, M., 十月 1 2004, 於: Cancer Chemotherapy and Pharmacology. 54, 4, p. 331-342 12 p.

研究成果: 雜誌貢獻 › 文章 › 同行評審

90 引文斯高帕斯（Scopus）

A phase I trial of escalating doses of cixutumumab (IMC-A12) and sorafenib in the treatment of advanced hepatocellular carcinoma

El-Khoueiry, A. B., O’Donnell, R., Semrad, T. J., Mack, P., Blanchard, S., Bahary, N., Jiang, Y., Yen, Y., Wright, J., Chen, H., Lenz, H. J. & Gandara, D. R., 五月 1 2018, 於: Cancer Chemotherapy and Pharmacology. 81, 5, p. 957-963 7 p.

研究成果: 雜誌貢獻 › 文章 › 同行評審

5 引文斯高帕斯（Scopus）

A phase-I trial of systemic heat and adriamycin (A)

Bull, J. M., Whang-Peng, J. & Lees, D. E., 一月 1 1979, 於: Proceedings of the American Association for Cancer Research. Vol. 20

研究成果: 雜誌貢獻 › 文章 › 同行評審

5 引文斯高帕斯（Scopus）

Aphonia and quadriplegia-A rare complication following epidural labor analgesia

Liu, F. L., Cherng, Y-G. & Chang, H-C., 九月 2008, 於: Acta Anaesthesiologica Taiwanica. 46, 3, p. 142-145 4 p.

研究成果: 雜誌貢獻 › 文章 › 同行評審

1 引文斯高帕斯（Scopus）

開啟存取

150 引文斯高帕斯（Scopus）

Apical segmental dysfunction in hypertrophic cardiomyopathy: Progression into end-stage heart failure with sudden cardiac death

Ko, Y. L., Lin, J. L., Lei, M. I., Chen, J. J., Tsou, S. S., Kuan, P. & Lien, W. P., 一月 1 1995, 於: Cardiology (Switzerland). 86, 5, p. 436-440 5 p.

研究成果: 雜誌貢獻 › 文章 › 同行評審

5 引文斯高帕斯（Scopus）

A picoampere-sensitivity readout circuit for nanosensor array

Wang, X. Z., Lei, X., Zhang, X. C., Wu, S. Y., Liu, C. J., Luo, M. C. & Li, Y. D., 一月 1 2015, 於: Nanoscience and Nanotechnology Letters. 7, 3, p. 292-295 4 p.

研究成果: 雜誌貢獻 › 文章 › 同行評審

Apigenin inhibits HGF-promoted invasive growth and metastasis involving blocking PI3K/Akt pathway and β4 integrin function in MDA-MB-231 breast cancer cells

Lee, W. J., Chen, W. K., Wang, C. J., Lin, W. L. & Tseng, T. H., 一月 15 2008, 於: Toxicology and Applied Pharmacology. 226, 2, p. 178-191 14 p.

研究成果: 雜誌貢獻 › 文章 › 同行評審

150 引文斯高帕斯（Scopus）

為 研究成果 進行篩選

搜尋結果

為研究成果進行篩選